Natera

Protect Health and Inform Earlier, More Targeted Interventions

Austin, TX, and San Carlos, CA 1 open role Website LinkedIn

Built from public information about Natera. Not yet managed by the company.

Our Signatera test is a personalized tumor-informed circulating tumor DNA assay that requires a deep understanding of mechanism design and sensor fusion. We've developed a novel approach to analyzing cell-free DNA that's enabled us to detect cancer biomarkers with unprecedented accuracy. This technology has the potential to revolutionize the way cancer is diagnosed and treated, and we're committed to making it a standard part of oncology care. Our team is working to scale this technology to meet the needs of patients and clinicians around the world.

About

Natera is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.

Projects

Signatera

a personalized tumor-informed circulating tumor DNA assay

Panorama

a test for identifying risk of severe genetic conditions

Prospera

a test for detecting organ injury

Open roles

Associate Director/Sr. Manager, Health Economics & Outcomes Research-Oncology

US Remote

Position Summary We are seeking a strategic, analytical, and highly collaborative leader to serve as our Associate Director/Senior Manager of Health Economics & Outcomes Research (HEOR) Oncology. In this high-impact role, you will lead the development and execution of health …

Applies on the company’s site